get a key
steadybase-$ company ANVS
account_id none on file
legal_name Annovis Bio, Inc.
ticker ANVS
cik 1477845
domain annovisbio.com
entry_point_account_id none on file
name Annovis Bio Inc.
exchange NYSE
sector Health Care
hq Malvern, PA, United States
calls 0 filings 4 executives 5 family 0
why_nownone on file
callsnone on file
filings
Maria Maccecchini, President and Chief Executive Officer

filing / Sep 11, 2026 / receipt

Name: Maria Maccecchini Title: Chief Executive Officer

filing / Sep 11, 2026 / receipt

For the three months ended March 31, 2026, General and administrative expenses were increased primarily due to $0.1 million of severance expense related to the Company entering into a separation agreement with its Chief Financial Officer.

filing / May 15, 2026 / receipt

In March 2026, the Company entered into a separation agreement with its Chief Financial Officer and incurred $ 0.1 million of severance expense, which was recorded to General and administrative expenses in the Company’s Statement of operations for the three months ended March 31, 2026.

filing / May 15, 2026 / receipt

executives
Andrew Walsh Principal Financial Officer - receipt
Henry Hagopian III Chief Financial Officer - receipt
Maria Maccecchini President and Chief Executive Officer - receipt
Mark Guerin Chief Financial Officer - receipt
William Fricker Interim Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2025-09-29 Chief Financial Officer, appointed sec_8k
2025-08-15 Acting Chief Financial Officer, appointed sec_8k
2025-05-13 Principal Financial Officer, appointed sec_8k
2025-03-27 Interim Chief Financial Officer, appointed sec_8k
2024-12-09 Chief Financial Officer, appointed sec_8k
2022-08-30 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$